Pharmanet Group

PharmaNet Development Group was a leading global contract research organization (CRO) that provided a comprehensive range of clinical development services to the pharmaceutical, biotechnology, and medical device industries. The company specialized in Phase I through Phase IV clinical trials, offering expertise in clinical trial management, data management, biostatistics, and regulatory affairs. Founded in 1996 and headquartered in Princeton, New Jersey, PharmaNet established a significant global footprint with operations in more than 35 countries. The company was particularly recognized for its strong focus on complex therapeutic areas, including oncology, neuroscience, and infectious diseases. In 2011, PharmaNet was acquired by inVentiv Health for approximately $600 million, and following a subsequent merger with INC Research, its legacy operations now form part of Syneos Health.